Trade Mark Journal No.2025/039 26 September 2025

UK00004265241 17 September 2025 (5)

Image for mark UK00004265241 AUJEMFLU ADJUVANTED CELL-BASED TRIVALENT INFLUENZA VACCINE
International priority date claimed: 26 August 2025 (United States of America) (99/358160)
Class 5
Vaccines.

Seqirus Inc.

Representative: Baker & McKenzie LLP